Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-130864
Filing Date
2022-04-29
Accepted
2022-04-29 09:05:11
Documents
7
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d412608ddef14a.htm DEF 14A 1026314
2 GRAPHIC g4126084dsp006.jpg GRAPHIC 2419
3 GRAPHIC g4126084dsp006b.jpg GRAPHIC 3650
4 GRAPHIC g412608g15a15.jpg GRAPHIC 72155
5 GRAPHIC g412608g36i66.jpg GRAPHIC 6692
6 GRAPHIC g412608g59h58.jpg GRAPHIC 64791
7 GRAPHIC g412608g63v72.jpg GRAPHIC 54907
  Complete submission text file 0001193125-22-130864.txt   1306260
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 22870642
SIC: 2834 Pharmaceutical Preparations